Rush University Medical Center
Hodgkin Lymphoma: Managing Brentuximab Vedotin/CPI Dual Refractory Patients
By
Rush University Medical Center
FEATURING
Vaishalee Kenkre
By
Rush University Medical Center
FEATURING
Vaishalee Kenkre
Login to view comments.
Click here to Login